drugset / Trial / NCT06513923

Comparison of Remimazolam and Propofol on Emergence in Elderly Orthopedic Patients Under General Anesthesia

NCT06513923

Phase 4 Completed 136 enrolled Central South University
RandomizedParallel-groupTriple-blindPrevention

Summary

Purpose: This study aims to compare the emergence time among three anesthesia regimens: remimazolam, remimazolam with flumazenil, and propofol in elderly patients undergoing hip replacement surgery. Background: Previous studies have shown that flumazenil accelerates emergence time when used with remimazolam. Remimazolam and propofol have comparable emergence times, although remimazolam can be up to 5 minutes longer than propofol.

Timeline

Start
2023-02-01
Primary completion
2023-09-30
Completion
2023-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Flumazenil Small molecule
Subject Propofol Small molecule 6 mg/kg
Subject Propofol Small molecule 8 mg/kg
Subject Remimazolam Small molecule 0.3 mg/kg
Subject Remimazolam Small molecule 0.7 mg/kg

Indications

No indication recorded.